Even though it is sponsored by three organizations, the joint Molecular Targets meeting of the American Association for Cancer Research, the National Cancer Institute, and the European Organisation for Research and Treatment of Cancer (AACR-NCI-EORTC) is smaller than the annual meetings of the big organizations – including that of AACR itself.
BOSTON — The Molecular Targets meeting, a joint endeavor of the American Association for Cancer Research, the National Cancer Institute, and the European Organisation for Research and Treatment of Cancer (AACR-NCI-EORTC), wrapped up a lively four days on Monday with a discussion of "the in vitro patient."
BOSTON – Among the data presented at the joint Molecular Targets meeting of the American Association for Cancer Research, the National Cancer Institute, and the European Organisation for Research and Treatment of Cancer (AACR-NCI-EORTC) were phase I trial as well as preclinical results for the newest member of the a poly-ADP ribose polymerase (PARP) inhibitor club.
Even though it is sponsored by three organizations, the joint Molecular Targets meeting of the American Association for Cancer Research, the National Cancer Institute, and the European Organisation for Research and Treatment of Cancer (AACR-NCI-EORTC) is smaller than the annual meetings of the big organizations – including that of AACR itself.
Scientists reported Thursday on a class of molecules that could partially dissolve cataracts in mice, as well as human cataracts that had been surgically removed.
Researchers gained unexpected new insights into the how the blood-brain barrier regulates its permeability, when knocking out the TAM family of receptor tyrosine kinases made animals more vulnerable to viral infections rather than protecting them.
A commensal strain of Escherichia coli was able to protect mice from the wasting syndrome cachexia, giving both new insights into how the microbiome contributes to health, and a possible new way of fighting, if not infections themselves, then their sequelae.
Several recent studies have given new insights into the molecular underpinnings of post-traumatic stress disorder (PTSD) and its relationship to depression.
